EXOZYMES INC. Increase (Decrease) in Due to Related Parties
EXOZYMES INC. (EXOZ) reported Increase (Decrease) in Due to Related Parties of -$5.33 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2026-08-13
- EXOZYMES INC. increase (decrease) in due to related parties for the quarter ending 2026-06-30 was -$13.41K.
- EXOZYMES INC. increase (decrease) in due to related parties for the quarter ending 2026-03-31 was $8.08K.
- EXOZYMES INC. increase (decrease) in due to related parties for the quarter ending 2025-12-31 was -$5.75K.
- EXOZYMES INC. increase (decrease) in due to related parties for the quarter ending 2025-09-30 was $11.43K.
- EXOZYMES INC. increase (decrease) in due to related parties for fiscal 2025 was -$26.53K.
- EXOZYMES INC. increase (decrease) in due to related parties for fiscal 2024 was -$4.24M, a 2168.48% decline from fiscal 2023.
- EXOZYMES INC. increase (decrease) in due to related parties for fiscal 2023 was $205.13K.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$5.33K 10-Q · filed 2026-08-13 | -$11.09K derived: sum of 3 quarters · filed 2026-08-13 | $346.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $8.08K 10-Q · filed 2026-05-14 | $2.32K derived: sum of 2 quarters · filed 2026-05-14 | $13.75K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | -$5.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $5.68K derived: sum of 2 quarters · filed 2026-03-30 | -$26.53K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $11.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$20.78K 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | -$32.21K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | -$4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$4.35M derived: sum of 2 quarters · filed 2026-03-30 | -$5.56M derived: sum of 3 quarters · filed 2026-03-30 | -$4.24M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$101.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.32M derived: sum of 2 quarters · filed 2025-11-13 | $2.74K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $104.23K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $1.32M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $205.13K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |